These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3319529

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K, Josse RG.
    CMAJ; 1996 Oct 01; 155(7):962-5. PubMed ID: 8837547
    [Abstract] [Full Text] [Related]

  • 24. Calcitonin and estrogens.
    Agnusdei D, Civitelli R, Camporeale A, Gennari C.
    J Endocrinol Invest; 1990 Sep 01; 13(8):625-30. PubMed ID: 2273204
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL, Loft AG, Møller N, Weeke J, Eriksen EF, Mosekilde L, Charles P.
    J Bone Miner Res; 1997 Jan 01; 12(1):78-88. PubMed ID: 9240729
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
    Ebeling PR, Russell RG.
    Int J Clin Pract; 2003 Oct 01; 57(8):710-8. PubMed ID: 14627183
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
    Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F.
    Lancet; 1997 Aug 23; 350(9077):550-5. PubMed ID: 9284777
    [Abstract] [Full Text] [Related]

  • 38. Alternative strategies for prevention of postmenopausal osteoporosis.
    Lindsay R.
    Public Health Rep; 1989 Aug 23; 104 Suppl(Suppl):66-70. PubMed ID: 2517704
    [Abstract] [Full Text] [Related]

  • 39. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC, Fowler SE, Detter JR, Sherman SS.
    J Clin Endocrinol Metab; 2001 Aug 23; 86(8):3618-28. PubMed ID: 11502787
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.